Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Stapokibart Injection in Patients With CRSwNP

NCT07483268 is registered in ClinicalTrials.gov with Chengdu Kangnuoxing Biopharma,Inc. as lead sponsor.

NCT NCT07483268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07483268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Stapokibart Injection in Patients With CRSwNP
Lead sponsor
Chengdu Kangnuoxing Biopharma,Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 29, 2026
Completion date
February 29, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crswnp